Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 3/20 | 0.41 |
| ▸ | RXRB | P28702 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.38 |
| ▸ | MAP3K8 | P41279 | 3/20 | 0.35 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21157898 | 0.87 | ALDH1A1 (0.35) | RXRARXRBALDH1A1MAPTKIF11 | |
| SCHEMBL21156613 | 0.87 | ALDH1A1 (0.35) | RXRARXRBALDH1A1MAPTKIF11 | |
| SCHEMBL21157801 | 0.86 | GPR84 (0.35) | RXRARXRBALDH1A1MAPTKIF11 | |
| SCHEMBL21157165 | 0.86 | ABCG2 (0.41) | RXRARXRBALDH1A1MAPTMAPK1 | |
| SCHEMBL10018874 | 0.80 | KIF11 (0.37) | RXRARXRBALDH1A1MAPTKIF11 | |
| SCHEMBL21157789 | 0.80 | MAP3K8 (0.37) | DHODHMAP3K8LOXL2MAPK1MAP2K1 | |
| SCHEMBL21157902 | 0.79 | ALDH1A1 (0.45) | RXRARXRBALDH1A1MAPTKIF11 | |
| SCHEMBL10443202 | 0.79 | ALOX5 (0.41) | RXRARXRBALDH1A1MAPTRXRG | |
| SCHEMBL21157956 | 0.78 | RXRA (0.40) | RXRARXRBALDH1A1MAPTKIF11 | |
| SCHEMBL10443009 | 0.77 | ALDH1A1 (0.36) | RXRARXRBALDH1A1MAPTKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190214577-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL, POLYMER, MIXTURE, FORMULATION, AND ORGANIC ELECTRONIC DEVICE | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190214577-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL, POLYMER, MIXTURE, FORMULATION, AND ORGANIC ELECTRONIC DEVICE | TEAD2, TEAD3, TEAD1 | RXRA 3879/4885RXRB 3716/4885ALDH1A1 1545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.